Skip to main content
Clinical Trials/NCT03086915
NCT03086915CompletedNot Applicable

Myorelaxation Practice in Paediatric Anesthesia: Retrospective Study

Brno University Hospital1 site in 1 country1,650 target enrollmentStarted: March 5, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,650
Locations
1
Primary Endpoint
Percentage of neuromuscular block reversal

Study Overview

Brief Summary

In retrospective data search the investigators will identified the percentage of patients with muscle relaxants administered during perioperative period. The block reversal, typ of drug, percentage of cases with and without reversal will be identified.

Detailed Description

The actual percentage of surgeries with the muscle relaxants administered during perioperative period in paediatric patients remain unclear because many surgeries are being performed without muscle relaxation. In this retrospective study, the anesthesiology perioperative data from January 2016 till December 2016 in the tertiary center od Pediatric anesthesia will be searched for the percentage of surgeries with muscle relaxants administered. Type of surgery, age, weight, duration u surgery, muscle relaxants drug and percentage of block reversal will be identified.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
— to 20 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • paediatric patients
  • the study period (1/2016-12/2016)
  • neuromuscular blocking agent administration during surgery

Exclusion Criteria

  • surgery without neuromuscular blockade

Arms & Interventions

Patients with neuromuscular block

Neuromuscular blocking agent administrated during surgery to the paediatric patient

Intervention: Neuromuscular Blocking Agent (Drug)

Outcomes

Primary Outcomes

Percentage of neuromuscular block reversal

Time Frame: 1 year

The actual percentage of paediatric patients with perioperative neuromuscular blockade with active pharmacology block reversal at the end of surgery

Secondary Outcomes

  • Percentage of surgeries without muscle relaxant administration(1 year)
  • Type of neuromuscular blocking agent in paediatric anesthesiology practice(1 year)

Investigators

Sponsor
Brno University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Petr Štourač, MD

doc. MD. Ph.D

Brno University Hospital

Study Sites (1)

Loading locations...

Similar Trials